Provided by Tiger Trade Technology Pte. Ltd.

Insulet

241.93
-1.2200-0.50%
Post-market: 242.340.4100+0.17%19:25 EST
Volume:1.10M
Turnover:265.23M
Market Cap:17.02B
PE:70.11
High:244.51
Open:242.65
Low:240.03
Close:243.15
52wk High:354.88
52wk Low:230.05
Shares:70.35M
Float Shares:70.08M
Volume Ratio:0.97
T/O Rate:1.56%
Dividend:- -
Dividend Rate:- -
EPS(TTM):3.45
EPS(LYR):5.78
ROE:19.68%
ROA:8.74%
PB:12.30
PE(LYR):41.83

Loading ...

BTIG Keeps Their Buy Rating on Insulet (PODD)

TIPRANKS
·
Feb 05

Insulet bringt Omnipod 5 und Omnipod Discover in den Nahen Osten

Reuters
·
Feb 05

Stifel Adjusts Price Target on Insulet to $350 From $370, Maintains Buy Rating

MT Newswires Live
·
Feb 05

Insulet Extends Key Supply Agreement with NXP USA

TIPRANKS
·
Feb 04

Insulet Corp. Stock Outperforms Competitors Despite Losses On The Day

Dow Jones
·
Feb 04

Insulet Corporation verlängert Liefervertrag mit NXP USA

Reuters
·
Feb 04

Insulet’s Omnipod M Study Completes Key Milestone in Type 2 Diabetes Onboarding

TIPRANKS
·
Jan 31

Insulet Corp. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
Jan 28

Insulet Corp. Stock Slides 3.0%, Underperforms Peers

Dow Jones
·
Jan 24

Insulet Completes Key Omnipod 5 SmartAdjust 2.0 Study, Setting Up Next Growth Phase

TIPRANKS
·
Jan 23

Analysts Conflicted on These Healthcare Names: Insulet (PODD) and Gilead Sciences (GILD)

TIPRANKS
·
Jan 22

Insulet Corp. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
Jan 21

Goldman Sachs Adjusts Price Target on Insulet to $363 From $365, Maintains Buy Rating

MT Newswires Live
·
Jan 16

Insulet Corporation highlights diabetes management leadership and market growth in new investor presentation

Reuters
·
Jan 14

Insulet (PODD) Receives a Buy from Bernstein

TIPRANKS
·
Jan 14

Wells Fargo Sticks to Their Buy Rating for Insulet (PODD)

TIPRANKS
·
Jan 13

Insulet Corp. Stock Slips 3.6%, Underperforms Peers

Dow Jones
·
Jan 13

Insulet Shares Fall After Barclays Downgrade

MT Newswires Live
·
Jan 13

Insulet Cut to Underweight From Equal-Weight by Barclays

Dow Jones
·
Jan 12

Barclays downgrades Insulet to Underweight on intensifying competition

TIPRANKS
·
Jan 12